WASHINGTON (dpa-AFX) - While reporting financial results for the fourth quarter on Monday, pet healthcare provider IDEXX Laboratories, Inc. (IDXX) initiated its earnings and revenue guidance for the full-year 2025, in line with analysts' estimates.
For fiscal 2025, the company now projects earnings in a range of $11.74 to $12.24 per share on revenues between $4.055 billion and $4.170 billion, with revenue growth of 4 to 7 percent and organic revenue growth of 6 to 9 percent.
On average, analysts polled by Thomson Reuters expect the company to report earnings of $11.84 per share on revenues of $4.15 billion for the year. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
Copyright(c) 2025 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
© 2025 AFX News
